425: Strive-Semler Merger: Cautionary Statement on Risks

Strive, Inc. reposts a cautionary statement on X.com regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• The communication, reposted by Strive Board Member Pierre Rochard on November 10, 2025, serves as a cautionary statement regarding forward-looking statements.
• Forward-looking statements relate to the outlook, strategic and financial benefits, timing of closing, and integration of the combined businesses.
• Investors are cautioned that actual results may differ materially from anticipated results due to various risks and uncertainties.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, with the SEC for the proposed transaction.
• Stockholders of Semler Scientific will receive a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is primarily a cautionary statement regarding a proposed merger, emphasizing risks associated with forward-looking statements. It is neutral in terms of new positive or negative news, but the extensive list of risks slightly dampens sentiment by highlighting potential challenges.

Positives

• Anticipated strategic benefits and financial benefits from the proposed transaction.
• Expected impact of the proposed transaction on the combined company's future financial performance.
• Anticipated cost savings and strategic gains from the integration.

Negatives

• Potential for the integration of the two companies to be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including cost savings and positive impacts on future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, and there is no assurance that actual results will not differ materially from any projected future results.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on November 10, 2025.
• Management of Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The filing mentions "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets," indicating that the combined entity may be involved in or exposed to the cryptocurrency market. This suggests a strategic move by one or both companies into digital asset management, potentially differentiating them within their traditional sectors and aligning with broader industry trends of corporate adoption of digital assets.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution for Strive's shareholders due to the issuance of additional Class A common stock in connection with the proposed transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets